http://www.nature.co...eu2016220a.html
Chronic myeloid leukemia patients call for quality and consistency when generics are introduced to treat their cancer
Started by
gerry
, Aug 29 2016 02:06 AM
4 replies to this topic
#2
douglaskeeth
-
- Members
-
- 1 posts
New Member
Posted 29 August 2016 - 04:17 PM
Novartis shills creating doubt or really a thing?
#3
Antilogical
-
- Members
-
- 284 posts
Advanced Member
- LocationPittsburgh, PA
Posted 29 August 2016 - 04:57 PM
The Conflict of Interest section toward the bottom of the paper is interesting....
Dx: Sudden severe anemia detected 07/2011, followed by WBC spike. CML Dx 02/2012.
Rx: 03/2012-Gleevec400. Reduced 02/2013 to Gleevec300 due to side effects (low blood counts).
Response: PCR-Und within 7 mo. on G400. Maintained MMR4-MMR4.5 on G300. PCR-Und since 02/2016.
#4
gerry
-
- Members
-
- 1,035 posts
Advanced Member
Posted 29 August 2016 - 05:04 PM
A few of them are patient advisors to the drug companies and I don't necessarily agree with all of their recommendations; but I figure I would be wondering about how good the generics are if my doc was looking to switch me.
#5
edenation
-
- Members
-
- 13 posts
Member
- LocationSingapore
Posted 09 November 2016 - 08:27 AM
I have been on generics for close to 6 years and have minimal side effects
1 user(s) are reading this topic
0 members, 1 guests, 0 anonymous users
